文献速递精神分裂症与精神病性障碍

首发精神病早期干预服务延长三年的随机单盲临床试验

Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial.
PubMed 文献 · World Psychiatry · 2017-01-01

该随机单盲试验将220例18-35岁首发精神病患者随机分为延长早期干预服务组(EEIS,N=110)和常规照护组(N=110),比较三年延长服务与三年常规照护的效果。结果显示EEIS组在阳性症状、阴性症状及总症状的累积缓解时间上均显著长于常规照护组,且治疗留存时间和治疗单元数更多。

要点

  • 延长早期干预服务三年可显著延长阳性症状和阴性症状的累积缓解时间。
  • EEIS组患者治疗留存时间更长且接受的治疗单元数更多。
  • 治疗时长对阳性症状缓解有独立效应,治疗单元数对阴性症状和总症状缓解有影响。

核心结论

  • 首发精神病患者在接受两年早期干预服务后,再延长三年早期干预服务比转入常规照护能更久地维持阳性和阴性症状缓解。

研究设计与样本

  • 随机单盲临床试验,采用 urn 随机化并按性别和物质滥用平衡,在蒙特利尔早期干预服务诊所招募220例18-35岁首发精神病患者,随机分为EEIS组(N=110)和常规照护组(N=110)。

主要发现

  • EEIS组阳性症状平均缓解时间显著长于常规照护组(92.5 vs. 63.6周,t=4.47,p<0.001)。
  • EEIS组阴性症状平均缓解时间显著长于常规照护组(73.4 vs. 59.6周,t=2.84,p=0.005)。
  • EEIS组阳性与阴性症状合计平均缓解时间显著长于常规照护组(66.5 vs. 56.7周,t=2.25,p=0.03)。
  • EEIS组通过医生接触的治疗留存时间更长(平均131.7 vs. 105.3周,t=3.98,p<0.001),通过其他卫生保健提供者的治疗留存时间也更长(134.8±37.7 vs. 89.8±55.2,t=6.45,p<0.0001)。
  • EEIS组接受的治疗单元数更多(医生提供平均74.9 vs. 39.9,t=4.21,p<0.001;其他卫生专业人员提供57.3 vs. 28.2,t=4.08,p<0.001)。

关键数值与推荐

  • 治疗时长对阳性症状缓解时长有独立效应(t=2.62,p=0.009)。
  • 任何卫生保健提供者提供的治疗单元数对阴性症状缓解时长有影响(t=-2.70,p=0.008),对总症状缓解时长也有影响(t=-2.40,p=0.02)。
  • 事后分析显示,基于随机化时更好的临床特征被分配至初级照护的患者在研究结束时仍维持更好的结局,尤其是阴性症状缓解。

临床怎么用

  • 对于已完成两年早期干预服务的首发精神病患者,继续延长早期干预服务三年可能有助于延长症状缓解时间。
  • 延长早期干预服务可能影响政策制定,支持将早期干预服务延长至当前两年以上。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This study aimed to determine if, following two years of early intervention service for first-episode psychosis, three-year extension of that service was superior to three years of regular care. We conducted a randomized single blind clinical trial using an urn randomization balanced for gender and substance abuse. Participants were recruited from early intervention service clinics in Montreal. Patients (N=220), 18-35 years old, were randomized to an extension of early intervention service (EEIS; N=110) or to regular care (N=110). EEIS included case management, family intervention, cognitive behaviour therapy and crisis intervention, while regular care involved transfer to primary (community health and social services and family physicians) or secondary care (psychiatric outpatient clinics). Cumulative length of positive and negative symptom remission was the primary outcome measure. EEIS patients had a significantly longer mean length of remission of positive symptoms (92.5 vs. 63.6 weeks, t=4.47, p<0.001), negative symptoms (73.4 vs. 59.6 weeks, t=2.84, p=0.005) and both positive and negative symptoms (66.5 vs. 56.7 weeks, t=2.25, p=0.03) compared to regular care patients. EEIS patients stayed in treatment longer than regular care patients (mean 131.7 vs. 105.3 weeks, t=3.98, p<0.001 through contact with physicians; 134.8 ± 37.7 vs. 89.8 ± 55.2, t=6.45, p<0.0001 through contact with other health care providers) and received more units of treatment (mean 74.9 vs. 39.9, t=4.21, p<0.001 from physicians, and 57.3 vs. 28.2, t=4.08, p<0.001 from other health care professionals). Length of treatment had an independent effect on the length of remission of positive symptoms (t=2.62, p=0.009), while number of units of treatment by any health care provider had an effect on length of remission of negative symptoms (t=-2.70, p=0.008) as well as total symptoms (t=-2.40, p=0.02). Post-hoc analysis showed that patients randomized to primary care, based on their better clinical profile at randomization, maintained their better outcome, especially as to remission of negative symptoms, at the end of the study. These data suggest that extending early intervention service for three additional years has a positive impact on length of remission of positive and negative symptoms compared to regular care. This may have policy implications for extending early intervention services beyond the current two years.

来源:World Psychiatry,查看原文。版权归原作者所有。

引用

  1. Malla A, Joober R, Iyer S, et al. Comparing three-year extension of early intervention service to regular care following two years of early intervention service in first-episode psychosis: a randomized single blind clinical trial. World Psychiatry. 2017. PMID: 28941098. doi:10.1002/wps.20456

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。